A 52-year-old man from rural Maharashtra is brought to the emergency department by his family after a suicide attempt via pesticide ingestion 2 hours ago. He had been increasingly withdrawn over the past 6 months, with poor sleep, difficulty concentrating at work, and persistent feelings of hopelessness. His wife reports he stopped attending social gatherings and expressed guilt about 'being a burden on the family.' He has no past psychiatric history. On examination, he is alert but appears psychomotor retarded. Blood glucose is 118 mg/dL, and electrolytes are normal. After medical stabilization, what is the most appropriate next step in psychiatric management?

Explanation

## Clinical Context and Risk Assessment This patient presents with: - **Active suicidal behavior** (recent suicide attempt via pesticide) - **Major Depressive Disorder** (6-month history of depressed mood, anhedonia, guilt, poor concentration, sleep disturbance) - **High suicide risk** (male, rural setting, expressed hopelessness and guilt, recent attempt) - **No past psychiatric history** (first episode) ### Suicide Risk Stratification | Risk Factor | Present in This Patient | |---|---| | Recent suicide attempt | Yes (2 hours ago) | | Male gender | Yes | | Age >40 years | Yes (52 years) | | Hopelessness | Yes (explicit) | | Social withdrawal | Yes | | Expressed guilt/burden | Yes | | Access to lethal means | Yes (pesticide) | **High-Yield:** This patient is at **VERY HIGH IMMEDIATE RISK** for repeat suicide attempt. Approximately 10% of patients who attempt suicide will eventually die by suicide; risk is highest in the immediate post-attempt period (first 24–48 hours). ### Appropriate Management in High-Risk Suicidal Depression **Key Point:** Inpatient psychiatric hospitalization with continuous observation is the standard of care for patients with recent suicide attempts and active suicidal ideation/intent. ### Why Inpatient Admission with Observation? 1. **Immediate safety:** Continuous observation prevents access to lethal means and allows rapid intervention if suicidal urges resurface 2. **Medication initiation under supervision:** SSRIs take 2–4 weeks to show effect; inpatient setting allows monitoring for serotonin syndrome, akathisia, or paradoxical worsening of suicidal ideation (black box warning in young adults) 3. **Psychosocial interventions:** Individual therapy, family counseling, and suicide risk assessment can be conducted in-hospital 4. **Medical monitoring:** Pesticide poisoning may have delayed complications; psychiatric and medical teams can collaborate 5. **Legal/ethical protection:** Involuntary admission may be warranted under mental health legislation (e.g., Mental Health Care Act, 2017 in India) **Clinical Pearl:** The first 48–72 hours post-attempt is the highest-risk window for repeat attempts. Inpatient care during this critical period significantly reduces mortality. ### Pharmacotherapy in Inpatient Setting - **SSRI initiation:** Fluoxetine, sertraline, or escitalopram are first-line - **Dosing:** Start at standard doses (e.g., fluoxetine 20 mg/day); titrate cautiously - **Monitoring:** Watch for serotonin syndrome, hyponatremia (SIADH), or increased suicidal ideation in first 1–2 weeks - **Augmentation:** If inadequate response at 4–6 weeks, consider adding lithium (mood stabilizer) or switching to another SSRI/SNRI **Mnemonic for inpatient suicide management:** **SAFE** = **S**uicide risk assessment, **A**dmission to secure unit, **F**irst-line pharmacotherapy, **E**ngagement with family and psychosocial support.